Literature DB >> 22595619

Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease.

Francesco E Pontieri1, Francesca Assogna, Alessandro Stefani, Mariangela Pierantozzi, Giuseppe Meco, Dario Benincasa, Carlo Colosimo, Carlo Caltagirone, Gianfranco Spalletta.   

Abstract

The severity of motor and non-motor symptoms of progressive supranuclear palsy (PSP) has a profound impact on social interactions of affected individuals and may, consequently, contribute to alter emotion recognition. Here we investigated facial emotion recognition impairment in PSP with respect to Parkinson's disease (PD), with the primary aim of outlining the differences between the two disorders. Moreover, we applied an intensity-dependent paradigm to examine the different threshold of encoding emotional faces in PSP and PD. The Penn emotion recognition test (PERT) was used to assess facial emotion recognition ability in PSP and PD patients. The 2 groups were matched for age, disease duration, global cognition, depression, anxiety, and daily L-Dopa intake. PSP patients displayed significantly lower recognition of sad and happy emotional faces with respect to PD ones. This applied to global recognition, as well as to low-intensity and high-intensity facial emotion recognition. These results indicate specific impairment of recognition of sad and happy facial emotions in PSP with respect to PD patients. The differences may depend upon diverse involvement of cortical-subcortical loops integrating emotional states and cognition between the two conditions, and might represent a neuropsychological correlate of the apathetic syndrome frequently encountered in PSP.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22595619     DOI: 10.1016/j.parkreldis.2012.04.023

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  11 in total

Review 1.  Social cognition in the FTLD spectrum: evidence from MRI.

Authors:  Maria Antonietta Magno; Elisa Canu; Massimo Filippi; Federica Agosta
Journal:  J Neurol       Date:  2021-11-19       Impact factor: 4.849

Review 2.  Measuring social cognition in frontotemporal lobar degeneration: a clinical approach.

Authors:  Maria Antonietta Magno; Elisa Canu; Federica Agosta; Massimo Filippi
Journal:  J Neurol       Date:  2021-11-19       Impact factor: 4.849

3.  Integrated case-based clinical approach in understanding pathways, complexities, pitfalls and challenges in neurodegenerative disorders.

Authors:  Aashitha Dhavala; Aditya Samitinjay; Praveen Khairkar; Vivek Podder; Amy Price; Syeda Hira Fatima; Rakesh Biswas
Journal:  Am J Neurodegener Dis       Date:  2022-06-20

4.  Behavioral abnormalities in progressive supranuclear palsy.

Authors:  Adam Gerstenecker; Kevin Duff; Benjamin Mast; Irene Litvan
Journal:  Psychiatry Res       Date:  2013-09-12       Impact factor: 3.222

5.  Emotion recognition in early Parkinson's disease patients undergoing deep brain stimulation or dopaminergic therapy: a comparison to healthy participants.

Authors:  Lindsey G McIntosh; Sishir Mannava; Corrie R Camalier; Bradley S Folley; Aaron Albritton; Peter E Konrad; David Charles; Sohee Park; Joseph S Neimat
Journal:  Front Aging Neurosci       Date:  2015-01-21       Impact factor: 5.750

Review 6.  Social Cognition Dysfunctions in Neurodegenerative Diseases: Neuroanatomical Correlates and Clinical Implications.

Authors:  Foteini Christidi; Raffaella Migliaccio; Hernando Santamaría-García; Gabriella Santangelo; Francesca Trojsi
Journal:  Behav Neurol       Date:  2018-04-26       Impact factor: 3.342

7.  Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism.

Authors:  Rocco Cerroni; Claudio Liguori; Alessandro Stefani; Matteo Conti; Elena Garasto; Mariangela Pierantozzi; Nicola B Mercuri; Sergio Bernardini; Giorgio Fucci; Renato Massoud
Journal:  Front Aging Neurosci       Date:  2020-06-16       Impact factor: 5.750

8.  Prediction of the Clinical Severity of Progressive Supranuclear Palsy by Diffusion Tensor Imaging.

Authors:  Yao-Liang Chen; Xiang-An Zhao; Shu-Hang Ng; Chin-Song Lu; Yu-Chun Lin; Jur-Shan Cheng; Chih-Chien Tsai; Jiun-Jie Wang
Journal:  J Clin Med       Date:  2019-12-24       Impact factor: 4.241

Review 9.  Active aging for individuals with Parkinson's disease: definitions, literature review, and models.

Authors:  Seyed-Mohammad Fereshtehnejad; Johan Lökk
Journal:  Parkinsons Dis       Date:  2014-08-25

Review 10.  Neuropsychiatric disturbances in atypical parkinsonian disorders.

Authors:  Daniele Belvisi; Isabella Berardelli; Antonio Suppa; Andrea Fabbrini; Massimo Pasquini; Maurizio Pompili; Giovanni Fabbrini
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.